GO:0005883 neurofilament: Components, Assembly and Research Methods, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0005883 neurofilament is a type IV intermediate filament located in the core of neuronal axons, composed of NF-L, NF-M, and NF-H heteropolymers.
• Neurofilaments are essential for radial axonal growth and determine axonal diameter, which directly affects nerve conduction velocity.
• Phosphorylation of neurofilament sidearms, especially on NF-M and NF-H, regulates filament spacing and axonal caliber.
• Neurofilament proteins are established biomarkers for neurodegenerative diseases, including amyotrophic lateral sclerosis and Alzheimer's disease.
• Dysregulation of neurofilament assembly or turnover is linked to neurological disorders such as Charcot-Marie-Tooth disease and Parkinson's disease.
• CRISPR-based models (knockout, knock-in, overexpression) enable precise dissection of neurofilament gene function in neurons.
Description
Neurofilaments are neuron-specific intermediate filaments that form the structural backbone of axons. They are obligate heteropolymers composed of three type IV polypeptides: neurofilament light (NF-L), neurofilament medium (NF-M), and neurofilament heavy (NF-H). These filaments are critical for radial axonal growth and for establishing axonal diameter, which in turn influences the speed of action potential propagation. Beyond their structural role, neurofilaments are dynamically regulated by phosphorylation and are increasingly recognized as biomarkers and potential therapeutic targets in neurodegenerative diseases. Researchers study neurofilaments to understand axonal development, neuronal injury, and disease mechanisms, and to develop diagnostic tools.
neurofilament At A Glance
| GO ID | GO:0005883 |
|---|---|
| GO term | neurofilament |
| Ontology | cellular_component |
| Synonym | type IV intermediate filament |
| Major function | Radial growth of axons and determination of axonal diameter |
| Composition | Heteropolymers of NF-L, NF-M, and NF-H |
| Location | Core of neuronal axons |
| Related diseases | Amyotrophic lateral sclerosis, Charcot-Marie-Tooth disease, Alzheimer's disease |
What Is GO:0005883?
GO:0005883 neurofilament is defined as a type of intermediate filament found in the core of neuronal axons. Neurofilaments are heteropolymers composed of three type IV polypeptides: NF-L, NF-M, and NF-H (for low, middle, and high molecular weight). They are responsible for the radial growth of an axon and determine axonal diameter.
Why Is neurofilament Important in Cell Biology?
Neurofilaments are essential for the structural integrity and function of axons, and their dysfunction is implicated in a wide range of neurological disorders. As the major determinant of axonal caliber, neurofilaments directly influence nerve conduction velocity and neuronal connectivity. Moreover, neurofilament proteins are released into biofluids upon axonal injury, making them promising biomarkers for disease diagnosis and progression monitoring. Understanding neurofilament biology is therefore critical for both basic neuroscience and clinical neurology.
• Neurofilaments determine axonal diameter, which affects the speed of nerve impulse conduction.
• They provide structural support and maintain the integrity of axons.
• Phosphorylation of neurofilament sidearms regulates filament spacing and axonal caliber.
• Neurofilament mutations are linked to Charcot-Marie-Tooth disease and other neuropathies.
• Neurofilament levels in cerebrospinal fluid and blood serve as biomarkers for axonal injury in multiple sclerosis, ALS, and Alzheimer's disease.
• Autoantibodies against neurofilaments are associated with neurodegeneration and can serve as diagnostic markers.
• Neurofilament dynamics are altered in response to neuronal stress and injury.
• They are targets for therapeutic strategies aimed at promoting axonal regeneration.
• Neurofilament proteins interact with other cytoskeletal elements and motor proteins to facilitate axonal transport.
• Studying neurofilaments helps elucidate mechanisms of neurodegenerative diseases and identify new treatment targets.
What Happens During neurofilament?
Synthesis and Assembly of Neurofilament Subunits
In simple terms: The cell builds the three neurofilament proteins and assembles them into long filaments.
Neurofilament proteins NF-L, NF-M, and NF-H are synthesized in the neuronal cell body and transported into axons. They co-assemble into heteropolymers, with NF-L being essential for filament formation. The assembly process involves the formation of dimers, tetramers, and higher-order structures that constitute the mature neurofilament.
Phosphorylation and Regulation of Filament Spacing
In simple terms: Adding phosphate groups to neurofilament tails controls how tightly filaments are packed.
The C-terminal tail domains of NF-M and NF-H are heavily phosphorylated, which regulates interactions between neurofilaments and determines axonal caliber. Phosphorylation is mediated by multiple kinases and is dynamically regulated during development and in response to injury.
Axonal Transport of Neurofilaments
In simple terms: Neurofilaments are moved along the axon like cargo on a train.
Neurofilaments are transported along axons by molecular motors, including kinesin and dynein, in a slow component of axonal transport. This transport is essential for maintaining the cytoskeletal network and for supplying distal axons with neurofilament proteins.
Turnover and Degradation
In simple terms: Old neurofilaments are broken down and replaced.
Neurofilament proteins undergo turnover through proteasomal and autophagic pathways. Dysregulation of these degradation pathways leads to neurofilament accumulation, which is a hallmark of several neurodegenerative diseases.
Key Genes Involved in GO:0005883 neurofilament
The following genes encode the core neurofilament proteins and key regulators of their assembly, phosphorylation, and turnover.
| Gene | Major Role | Research Relevance |
|---|---|---|
| NEFL | Encodes neurofilament light chain (NF-L) | Mutations cause Charcot-Marie-Tooth disease; essential for filament assembly |
| NEFM | Encodes neurofilament medium chain (NF-M) | Phosphorylation regulates axonal caliber; implicated in ALS |
| NEFH | Encodes neurofilament heavy chain (NF-H) | Phosphorylation affects filament spacing; biomarker for axonal injury |
| INA | Encodes alpha-internexin, a type IV intermediate filament | Co-assembles with neurofilaments in developing neurons |
| PRPH | Encodes peripherin, a type III intermediate filament | Forms heteropolymers with neurofilaments in peripheral neurons |
| KIF5A | Kinesin heavy chain involved in axonal transport | Mutations linked to ALS and spastic paraplegia |
| DCTN1 | Dynactin subunit involved in retrograde transport | Mutations associated with motor neuron disease |
| MAPT | Microtubule-associated protein tau | Interacts with neurofilaments; involved in Alzheimer's disease |
| GSK3B | Glycogen synthase kinase 3 beta | Phosphorylates neurofilament sidearms; regulates axonal caliber |
| CDK5 | Cyclin-dependent kinase 5 | Phosphorylates neurofilaments; implicated in neurodegeneration |
| PPP1R1A | Protein phosphatase 1 regulatory subunit | Dephosphorylates neurofilaments; modulates filament dynamics |
| SQSTM1 | Sequestosome 1 (p62) | Involved in autophagic degradation of neurofilaments |
| MAP1B | Microtubule-associated protein 1B | Cross-links neurofilaments to microtubules |
| NEFH | Neurofilament heavy chain | Phosphorylated form is a biomarker for ALS |
| NEFL | Neurofilament light chain | Blood biomarker for neuroaxonal injury |
| NEFM | Neurofilament medium chain | Autoantibody target in neurodegeneration |
| NEFH | Neurofilament heavy chain | Autoantibody target in neurodegeneration |
| NEFL | Neurofilament light chain | Autoantibody target in neurodegeneration |
How Is neurofilament Regulated?
Neurofilament expression and assembly are regulated at multiple levels. Transcription of NEFL, NEFM, and NEFH is controlled by neuronal transcription factors. Post-translationally, phosphorylation of the C-terminal domains of NF-M and NF-H by kinases such as GSK3B and CDK5 regulates filament spacing and axonal caliber. Phosphatases, including protein phosphatase 1, counteract this phosphorylation. Additionally, neurofilament turnover is regulated by the ubiquitin-proteasome system and autophagy, with SQSTM1/p62 playing a role in autophagic degradation. Dysregulation of these regulatory mechanisms contributes to neurofilament accumulation in neurodegenerative diseases.
neurofilament and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NEFL | Charcot-Marie-Tooth disease | Knockout mouse or patient-derived iPSC neurons |
| NEFH | Amyotrophic lateral sclerosis | Transgenic mouse overexpressing mutant NEFH |
| NEFM | Neurodegeneration with autoantibodies | Passive transfer of anti-NEFM antibodies in mice |
| NEFL | Alzheimer's disease | APP/PS1 mouse crossed with NEFL knockout |
| NEFH | Axonal injury biomarker | Controlled cortical impact model in rats |
Neurofilament mutations in Charcot-Marie-Tooth disease
Mutations in NEFL, NEFM, and NEFH cause Charcot-Marie-Tooth disease, a hereditary neuropathy characterized by axonal degeneration. These mutations often impair neurofilament assembly or transport, leading to reduced axonal caliber and progressive weakness.
Neurofilament proteins as biomarkers in amyotrophic lateral sclerosis
Phosphorylated neurofilament heavy chain (pNF-H) and neurofilament light chain (NFL) are elevated in the cerebrospinal fluid and blood of patients with amyotrophic lateral sclerosis (ALS). They serve as diagnostic and prognostic biomarkers for axonal injury and disease progression.
Autoantibodies against neurofilaments in neurodegeneration
Autoantibodies targeting neurofilament proteins have been detected in patients with various neurodegenerative conditions, including Alzheimer's disease and Parkinson's disease. These antibodies may serve as markers of neuroaxonal damage and could contribute to disease pathogenesis.
Neurofilament accumulation in Alzheimer's disease
In Alzheimer's disease, neurofilament proteins accumulate in neuronal perikarya and dystrophic neurites, often alongside tau pathology. This accumulation reflects impaired axonal transport and turnover, and correlates with cognitive decline.
From neurofilament-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does NEFL loss impair axonal caliber? | NEFL knockout mouse |
| Does a specific NEFH mutation cause ALS? | NEFH knock-in mouse expressing mutant allele |
| Can tagged NF-L be used to track filament transport? | Knock-in mouse with fluorescent tag on NEFL |
| Does overexpression of NF-H alter filament spacing? | Transgenic mouse overexpressing NEFH |
| What is the role of NEFM phosphorylation in vivo? | Point-mutation knock-in of phospho-deficient NEFM |
| Can CRISPR screen identify regulators of neurofilament assembly? | Genome-wide CRISPR knockout screen in iPSC-derived neurons |
How to Study the neurofilament Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Immunofluorescence | Neurofilament distribution and morphology | Axonal caliber and filament assembly |
| Western blot | Protein levels and phosphorylation | Quantification in cell and animal models |
| Live-cell imaging | Neurofilament transport dynamics | Axonal transport studies |
| ELISA/Simoa | Neurofilament levels in biofluids | Biomarker discovery in neurodegeneration |
| CRISPR knockout | Gene function loss | Identifying essential neurofilament genes |
| CRISPR knock-in | Tagged or mutant protein expression | Tracking filament dynamics in vivo |
| RNA-seq | Transcriptional changes | Neurofilament gene expression profiling |
| Proteomics | Protein interactions and modifications | Identifying neurofilament binding partners |
Imaging of neurofilament networks
Fluorescence microscopy, including confocal and super-resolution imaging, allows visualization of neurofilament assembly and transport in cultured neurons. Live-cell imaging with tagged neurofilament proteins reveals dynamic changes in filament organization.
Biochemical analysis of neurofilament proteins
Western blotting and immunoprecipitation are used to quantify neurofilament protein levels and phosphorylation states. These methods help assess assembly and turnover in cell and animal models.
Biomarker detection in biofluids
ELISA and Simoa assays detect neurofilament light and heavy chains in cerebrospinal fluid and blood, providing sensitive biomarkers for axonal injury in clinical and research settings.
Genetic manipulation and screening
CRISPR-Cas9 knockout, knock-in, and overexpression models enable functional studies of neurofilament genes. High-throughput CRISPR screens can identify modifiers of neurofilament pathology.
How CRISPR Can Be Used to Study GO:0005883 neurofilament
Knockout
CRISPR-Cas9 knockout of NEFL, NEFM, or NEFH in neuronal cell lines or iPSC-derived neurons can reveal their roles in filament assembly, axonal transport, and neuronal survival. Knockout models help determine whether a gene is essential for neurofilament formation.
Point Mutation
Introducing disease-associated point mutations (e.g., NEFL mutations found in Charcot-Marie-Tooth disease) using CRISPR base editing or HDR allows study of mutant protein behavior, including aggregation and impaired transport.
Knock-in
Knock-in of fluorescent tags (e.g., GFP) or epitope tags into endogenous NEFL, NEFM, or NEFH loci enables real-time tracking of neurofilament dynamics and interaction studies in live neurons.
Overexpression
CRISPR activation (CRISPRa) or transgenic overexpression of neurofilament genes can model neurofilament accumulation, a hallmark of neurodegenerative diseases, and test therapeutic interventions.
How EDITGENE Supports neurofilament Research
Researchers studying neurofilament-related genes often need to determine whether a candidate gene is causally involved in axonal pathology or serves as a biomarker. Precise genetic models are essential to dissect these mechanisms and to validate therapeutic targets.
Contact EDITGENE today to design your custom CRISPR model for neurofilament research.
Frequently Asked Questions About neurofilament
What is GO:0005883 neurofilament?
GO:0005883 neurofilament is a type of intermediate filament found in the core of neuronal axons, composed of NF-L, NF-M, and NF-H heteropolymers.
What genes are involved in neurofilament?
The core genes are NEFL, NEFM, and NEFH, which encode the light, medium, and heavy neurofilament subunits.
What is the function of neurofilament?
Neurofilaments determine axonal diameter and provide structural support for axons, influencing nerve conduction velocity.
How are neurofilaments regulated?
Neurofilament assembly and spacing are regulated by phosphorylation of NF-M and NF-H sidearms, as well as by turnover pathways.
What diseases are associated with neurofilament mutations?
Mutations in neurofilament genes cause Charcot-Marie-Tooth disease and are implicated in ALS and Alzheimer's disease.
Are neurofilaments used as biomarkers?
Yes, neurofilament light and heavy chains in biofluids are biomarkers for axonal injury in multiple sclerosis, ALS, and other neurodegenerative diseases.
How can I study neurofilament function?
CRISPR knockout, knock-in, and overexpression models combined with imaging and biochemical assays are common approaches.
What is the difference between NF-L, NF-M, and NF-H?
They are low, medium, and high molecular weight neurofilament subunits that co-assemble into heteropolymers.
Can neurofilament levels predict disease progression?
Elevated neurofilament levels in CSF and blood correlate with disease severity and progression in ALS and other conditions.
What CRISPR models are available for neurofilament research?
EDITGENE offers knockout, point mutation, knock-in, and overexpression models for neurofilament genes, as well as library screening and bioinformatics services.
Conclusion
Neurofilaments are fundamental components of the neuronal cytoskeleton, essential for axonal structure and function. Their dysregulation is a common feature of neurodegenerative diseases, and they serve as valuable biomarkers. Continued research using advanced CRISPR models will further elucidate neurofilament biology and aid in the development of targeted therapies.
References
- 1. Yuan A et al.. 2017. Neurofilaments and Neurofilament Proteins in Health and Disease.. Cold Spring Harb Perspect Biol 9(4) PMID: 28373358
- 2. Ding EA et al.. 2024. Neurofilament Biophysics: From Structure to Biomechanics.. Mol Biol Cell 35(5):re1 PMID: 38598299
- 3. Zmira O et al.. 2020. Anti-neurofilament antibodies and neurodegeneration: Markers and generators.. J Neuroimmunol 344:577248 PMID: 32344161
- 4. Sharma P et al.. 2024. Emerging Trends: Neurofilament Biomarkers in Precision Neurology.. Neurochem Res 49(12):3208-3225 PMID: 39347854
- 5. Hemingway C. 2023. Neurofilament as a biomarker - are we there yet?. Eur J Paediatr Neurol 45:A5 PMID: 37423817
- 6. Heckler I et al.. 2022. Phosphorylated neurofilament heavy chain: a potential diagnostic biomarker in amyotrophic lateral sclerosis.. J Neurophysiol 127(3):737-745 PMID: 35138963
- 7. Phillips CL et al.. 2023. Stability dynamics of neurofilament and GFAP networks and protein fragments.. Curr Opin Cell Biol 85:102266 PMID: 37866019
- 8. Gentil BJ et al.. 2015. Neurofilament dynamics and involvement in neurological disorders.. Cell Tissue Res 360(3):609-20 PMID: 25567110
